Day One Biopharmaceuticals Inc (DAWN) financials · rev $131.2M
Day One Biopharmaceuticals Inc (DAWN) rev $131.2M.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $131.2M | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| Net Income | -$95.5M | -$188.9M | -$142.2M | -$72.8M |
| EPS (Diluted) | $-1.02 | $-2.37 | $-2.17 | $-4.62 |
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | $582.8M | $376.0M | $349.1M |
| Current Assets | $0 | $0 | $0 |
| Cash & Equivalents | $125.0M | $230.8M | $85.3M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $80.0M | $29.5M | $17.0M |
| Current Liabilities | $0 | $0 | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $0 | $0 | $0 |
| Retained Earnings | $0 | $0 | $0 |
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Operating Cash Flow | -$78.1M | -$146.9M | -$109.9M | -$48.5M |
| CapEx | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$231.0M | $128.4M | -$255.1M | -$8.0M |
| Financing Cash Flow | $203.3M | $164.0M | $165.9M | $297.1M |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |
FAQ
What is DAWN P/E and revenue?
Day One Biopharmaceuticals Inc (DAWN) rev $131.2M.
What is DAWN revenue?
Day One Biopharmaceuticals Inc last cached revenue is $131.2M (FY2024).
Is DAWN profitable?
Day One Biopharmaceuticals Inc last cached net income is -$95.5M.
What are DAWN total assets?
Day One Biopharmaceuticals Inc last cached total assets are $582.8M.
What is DAWN free cash flow?
Day One Biopharmaceuticals Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.